University of Washington, the Seattle Cancer Care Alliance (SCCA), Fred Hutch, and Juno are all investing in the CTU, and Juno will also provide research funds to Fred
Patheon was selected to assist with the development of advanced INTAC based products including single-entity and fixed-dose combination solid oral dosage forms with immediate and modified release properties.
Under the collaboration, Rockland will provide and manage Formula’s specially hired preclinical research team. Further, Rockland will provide the classified research facilities for Formula’s preclinical development needs in
Following the redemption of a Priority Review Voucher with the submission, an FDA decision is anticipated in August 2016. Sanofi executive vice president of global diabetes & cardiovascular
33A is an antibody-drug conjugate (ADC) targeted to CD33 utilizing Seattle Genetics’ newest technology, comprising an engineered cysteine antibody (EC-mAb) stably linked to a highly potent DNA binding
The unrestricted grants will be awarded to organizations with a track record of excellence in results-driven research. Gilead Sciences executive vice president of research William Lee said: "For
ViiV Healthcare CEO Dominique Limet said: "As a result of these transactions, ViiV Healthcare now has one of the most robust HIV pipelines in the industry. "The assets
This announcement furthers the Company’s previously announced actions on October 22, 2015 to maximize efficiency and continue leveraging the strength of Perrigo’s global platform. A number of positions
Epilepsy is a brain disorder that causes people to have recurring seizures. A seizure is an episode, usually of relatively short duration, of abnormal brain activity. Seizures can
The FDA has extended the date for agency action by the standard period, from Feb. 27, 2016 to May 27, 2016. Following the Psychopharmacologic Advisory Committee meeting in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.